Improve Opioid Safety and Chronic Pain Management in Michigan Communities
Posted on July 15, 2020
The Michigan Center for Rural Health (MCRH) and the MHA Keystone Center have partnered to ensure that providers and health systems focus on preventing opioid-related morbidity and mortality.
Through this partnership, the MCRH and the MHA Keystone Center are offering a cloud-based guide to implementing the CDC Guideline for Prescribing Opioids for Chronic Pain, which was published in 2016 by the Centers for Disease Control and Prevention (CDC). The new resource is designed to help providers implement the federal guideline by:
- Summarizing the CDC Guideline for Prescribing Opioids for Chronic Pain with a focus on 12 key evidence-based recommendations.
- Offering clinical quality improvement measures that align with the CDC’s recommendations on prescribed opioids.
- Providing a deep dive into robust implementation strategies to establish sustainable improvements in clinical practice.
The target users for this resource are individuals who have the capability (clinical background), opportunity (involved in the care of patients with chronic pain), and motivation (passion for opioid safety, chronic pain management or quality improvement) to improve patient care. This includes prescribers, pharmacists, behavioral health professionals, opioid use disorder treatment program staff, and local opioid safety champions, to name a few.
The implementation guide can be accessed online by clicking the button labeled “Enroll for Free.” It is available to both MHA members and nonmembers; however, capacity for the resource is limited, and requests will be honored on a first-come, first-served basis.
Funding for this implementation resource is provided by the Michigan Department of Health and Human Services through the CDC Overdose Data to Action grant. This program aims to increase non-opioid and nonpharmacologic treatments for pain care when appropriate, decrease high-risk opioid prescribing and increase referrals to evidence-based treatment for opioid use disorder. For additional information, contact the MHA Keystone Center.
Posted in: Member News, Patient Safety & Quality